Detalhe da pesquisa
1.
Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.
Transfusion
; 62(9): 1894-1907, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916266
2.
Measurement of isoagglutinins in immunoglobulins for intravenous application by flow cytometry.
Anal Biochem
; 591: 113534, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821802
3.
Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.
Transfusion
; 60(7): 1381-1390, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488887
4.
Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports.
Transfusion
; 60(6): 1278-1286, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410287
5.
Hemolytic adverse effects of intravenous immunoglobulin: modeling predicts risk reduction with anti-A/B immunoaffinity chromatography and to a lesser extent with anti-A donor screening.
Transfusion
; 58(12): 2752-2756, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30284263
6.
Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility.
Transfusion
; 57(11): 2629-2638, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28840942
7.
Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency.
J Clin Immunol
; 36(3): 210-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26910102
8.
Clinical experience with an L-prolinestabilized 10 %intravenous immunoglobulin (Privigen®): real-life effectiveness and tolerability.
J Clin Immunol
; 34(7): 804-12, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24981039
9.
Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital-based cohort study in the US.
Am J Hematol
; 93(1): E17-E20, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983941
10.
Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
Circ Res
; 94(7): 918-25, 2004 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-14988229
11.
Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment.
BioDrugs
; 30(5): 441-451, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27646589
12.
Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke.
Cerebrovasc Dis
; 17(2-3): 204-11, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-14707423
13.
A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes.
Blood
; 103(11): 4028-35, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14976055